
Pfizer’s Ibrance was the star performer from the class of 2015 FDA approvals
Pfizer’s Ibrance was the star performer from the class of 2015 FDA approvals
$360-million settlement involved assistance funneled through a charity
New Cardinal Health survey sees the profession adjusting to value-based care
Now a national provider, Senderra’s new dispensing location is in Morrisville, NC
New survey finds weaknesses in patient privacy, funding oversight
The battle between pharma and PBMs over copays intensifies
Most pharmacists want more time to counsel patients; most are concerned with drug reimbursement issues
Integrating pharma communications with electronic health-record systems brings value to patients and providers
Biologics, RxCrossroads units will retain their identity
$700,000 fine to benefit New York State residents
Not compensating for speaker programs and sponsored meetings has affected marketing, says the firm
Devices modeled after the BD UltraSafe units
Company will now have three operational centers across the US
Virtual assistants delivering guidance from Accenture’s Intelligent Patient Platform
Electronic benefits verification (eBV) combines with patient access services
Platform will operate within IBM’s HyperLedger blockchain technology
The orphan drug will reach patients through a limited-distribution network of specialty pharmacies
The year-old-plus litigation highlights the value of customer master data
Alliance for Regenerative Medicine tries to rationalize how payers address economic value
Rare diseases are hard to treat; supporting the patient can be even more challenging
Leading US provider will produce 70 million doses in next several months
Tetraphase’s anticipated approval of an antibiotic will benefit from precise marketing targeting
The flood of new oncology drugs is challenging the ability of healthcare providers to determine best treatment choices
MyCubixx technology puts an interactive refrigerator in the patient’s home
PIM will eventually forge links from manufacturer to patient